SOX2 Is a Potential Novel Marker of Undifferentiated Thyroid Carcinomas

Background Thyroid cancer is a very common endocrine malignancy. Cancer stem cells are attributable to initiation, progression, and treatment failure in thyroid carcinoma. In the current study, immunostaining of SRY-box 2 (SOX2) in thyroid carcinoma is investigated. Material and methods Tissue micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomaa, Wafaey, Marouf, Azmi, Alamoudi, Asayil, Al-Maghrabi, Jaudah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805510/
https://www.ncbi.nlm.nih.gov/pubmed/33489519
http://dx.doi.org/10.7759/cureus.12102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805510/
https://www.ncbi.nlm.nih.gov/pubmed/33489519
http://dx.doi.org/10.7759/cureus.12102

Ejemplares similares